Key facts
- This page summarizes Geno J. Germano's Form 4 filing for PRECISION BIOSCIENCES INC (DTIL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 May 2026, 07:30.
Geno J. Germano - 20 May 2026 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)
- Reporting relationship
- Director
- Issuer ticker
- DTIL
- Reported as of
- 20 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 May 2026, 07:30:18 UTC
- Prior SEC filing
- 18 May 2026
- Next SEC filing
- 05 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dario Scimeca Attorney-in-Fact for Geno J. Germano
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Geno J. Germano filed Form 4 for PRECISION BIOSCIENCES INC (DTIL) on 22 May 2026.
Change
- Previous filing in this sequence was filed on 18 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001424383
Primary reporting owner
Germano Geno J
- Relationship
- Director
- Address
- C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW ST., SUITE A-100, DURHAM
- Signature
- /s/ Dario Scimeca Attorney-in-Fact for Geno J. Germano
- Signature date
- 22 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DTIL
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +21,000
- Change %
- +88%
- Price
- Shares after
- 44,883
- Date
- 20 May 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DTIL
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -21,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 20 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,000
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the vesting of Restricted Stock Units ("RSUs") on May 20, 2026.
Footnote F2
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
Footnote F3
On June 3, 2025 the Reporting person was granted RSUs. The RSUs vested on the earlier to occur of (i) June 3, 2026 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.